Literature DB >> 1346947

Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes.

N J Linker1, P Colonna, C A Kekwick, J Till, A J Camm, D E Ward.   

Abstract

It has been suggested that QT dispersion recorded on the surface electrocardiogram may be a predictor of arrhythmic events in patients with congenital QT prolongation. To evaluate this, 9 patients (6 female, mean age 17.6 years) with congenital long QT syndromes, all of whom had syncope and documented torsades de pointes, were studied. Patients were studied off treatment and during therapy with beta-blocking agents. Three patients were also studied after left stellate ganglionectomy. An age-matched control group was also studied. Good quality 12-lead electrocardiograms were recorded from all patients. For each lead, QT and RR intervals were measured, and QTc value was calculated. QT and QTc dispersions were calculated for each patient. Patients had a significantly longer mean QT interval compared with that of the control group (450 +/- 100 vs 359 +/- 63 ms; p = 0.015) at similar mean RR intervals (736 +/- 231 vs 783 +/- 289 ms), with a longer mean QTc value (0.53 +/- 0.08 vs 0.41 +/- 0.02 s1/2; p = 0.004). Patients also had longer QT and QTc dispersions compared with those of the control group (110 +/- 45 vs 43 +/- 12 ms [p = 0.004], and 0.108 +/- 0.03 vs 0.05 +/- 0.02 s1/2 [p = 0.002], respectively). QT and QTc dispersions on and off beta-blocking agents were not significantly different. Comparing patients with frequent and those with infrequent symptoms, there was no difference in QT or QTc dispersion either off treatment or during therapy with beta-blocking agents.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346947     DOI: 10.1016/0002-9149(92)90155-r

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  [Not Available].

Authors:  P Gödde; H P Müller; K Czerski; B Kessler; R Agrawal; M Oeff; H P Schultheiss
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1998-02

2.  Effects of beta-adrenergic antagonists on the QT measurements from exercise stress tests in pediatric patients with long QT syndrome.

Authors:  J R Kaltman; P S Ro; P Stephens; M G McBride; M I Cohen; R E Tanel; V L Vetter; L A Rhodes
Journal:  Pediatr Cardiol       Date:  2003-09-04       Impact factor: 1.655

3.  Measurement error as a source of QT dispersion: a computerised analysis.

Authors:  J A Kors; G van Herpen
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

4.  Computerised measurements of QT dispersion in healthy subjects.

Authors:  Y Gang; X H Guo; R Crook; K Hnatkova; A J Camm; M Malik
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

5.  QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome).

Authors:  D Frongillo; F Stocchi; F A Delfino; L Calò; L Bramante; F Antonucci; D De Nardo; S Ruggleri; D Cannata
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

6.  Adjustment of QT dispersion assessed from 12 lead electrocardiograms for different numbers of analysed electrocardiographic leads: comparison of stability of different methods.

Authors:  K Hnatkova; M Malik; J Kautzner; Y Gang; A J Camm
Journal:  Br Heart J       Date:  1994-10

Review 7.  QT dispersion.

Authors:  P D Higham; R W Campbell
Journal:  Br Heart J       Date:  1994-06

8.  QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy.

Authors:  K Sakata; M Shimizu; H Ino; M Yamaguchi; H Terai; K Hayashi; M Kiyama; T Hayashi; M Inoue; H Mabuchi
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Dispersion of regional wall motion abnormality in patients with long QT syndrome.

Authors:  K Nakayama; H Yamanari; F Otsuka; K Fukushima; H Saito; Y Fujimoto; T Emori; H Matsubara; S Uchida; T Ohe
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

10.  Use of lead adjustment formulas for QT dispersion after myocardial infarction.

Authors:  J M Glancy; C J Garratt; K L Woods; D P de Bono
Journal:  Br Heart J       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.